Caricamento...
Lentiviral Vector Platform for Production of Bioengineered Recombinant Coagulation Factor VIII
Patients with hemophilia A present with spontaneous and sometimes life-threatening bleeding episodes that are treated using blood coagulation factor VIII (fVIII) replacement products. Although effective, these products have limited availability worldwide due to supply limitations and product costs,...
Salvato in:
| Autori principali: | , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Publishing Group
2011
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3034847/ https://ncbi.nlm.nih.gov/pubmed/21081907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2010.239 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|